PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

por Hamadani, M., Graham, C. N., Liao, L., Zhang, K. H., Strat, H., Ungar, D., Ai, W., Chen, L., Carlo-Stella, C.
Publicado 2022